Frequent injections of high‑dose human umbilical cord mesenchymal stem cells slightly aggravate arthritis and skeletal muscle cachexia in collagen‑induced arthritic mice

An,Lemei; Chu,Tianshu; Wang,Liujun; An,Songtao; Li,Yalong; Hao,Hongbo; Zhang,Zhuoli; Yue,Han

doi:10.3892/etm.2021.10707

Frequent injections of high‑dose human umbilical cord mesenchymal stem cells slightly aggravate arthritis and skeletal muscle cachexia in collagen‑induced arthritic mice

Authors:
- Lemei An
- Tianshu Chu
- Liujun Wang
- Songtao An
- Yalong Li
- Hongbo Hao
- Zhuoli Zhang
- Han Yue
View Affiliations

Affiliations: Department of Rheumatology and Clinical Immunology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan 450003, P.R. China, Department of Cardiology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan 450003, P.R. China, Henan Key Laboratory of Stem Cell Differentiation and Modification, Stem Cell Research Center, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan 450003, P.R. China, Neuroscience Initiative, Advanced Science Research Center at the Graduate Center, City University of New York, New York, NY 10031, USA, Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing 100034, P.R. China
Published online on: September 7, 2021 https://doi.org/10.3892/etm.2021.10707
Article Number: 1272

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A single injection of low‑dose human umbilical cord‑derived mesenchymal stem cells (UC‑MSCs) has been previously demonstrated to relieve synovitis and bone erosion in animal models of arthritis, but whether frequent injections of high‑dose UC‑MSCs relieve arthritis and inhibit loss of muscle mass has remained elusive. In the present study, DBA/1 mice were randomly divided into three groups: Normal (wild‑type mice; n=11), collagen‑induced arthritis (CIA; n=12) and CIA treated with UC‑MSCs (n=11; 5x10⁶ UC‑MSCs per week for 3 weeks). Arthritis and skeletal muscle cachexia were evaluated until the end of the experiment on day 84. It was indicated that both the CIA and UC‑MSC groups had lower body weights compared with the normal mice. Clinical arthritis scores, hind ankle diameters, synovitis and bone erosion progressively increased and were similar between the CIA and UC‑MSC groups. Although there was no difference in food intake among the three groups, the normalized food intake of normal group was significantly higher than CIA group and UC‑MSC group from day 42 onwards; there was no significance on day 77 but this could be neglected. Furthermore, gastrocnemius muscle weight in the UC‑MSC group was significantly reduced compared with that in the CIA and normal groups. The UC‑MSC group had higher levels of proinflammatory cytokines, such as TNF‑α, IL‑6 and IL‑1β than those in the CIA group. However, the other cytokines assessed and the fibrosis indices in the CIA and UC‑MSC groups were not different from those in the control group and there was no inflammatory cell infiltration. Thus, frequent injections of high‑dose UC‑MSCs slightly aggravated synovitis and muscle cachexia in the murine CIA model and should therefore be avoided in the treatment of arthritis.

View Figures

View References

1	Aletaha D and Smolen JS: Diagnosis and management of rheumatoid arthritis: A review. JAMA. 320:1360–1372. 2018.PubMed/NCBI View Article : Google Scholar
2	Santo RCE, Fernandes KZ, Lora PS, Filippin LI and Xavier RM: Prevalence of rheumatoid cachexia in rheumatoid arthritis: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 9:816–825. 2018.PubMed/NCBI View Article : Google Scholar
3	Cohen S, Nathan JA and Goldberg AL: Muscle wasting in disease: Molecular mechanisms and promising therapies. Nat Rev Drug Discov. 14:58–74. 2015.PubMed/NCBI View Article : Google Scholar
4	Lin JZ, Liang JJ, Ma JD, Li QH, Mo YQ, Cheng WM, He XL, Li N, Cao MH, Xu D and Dai L: Myopenia is associated with joint damage in rheumatoid arthritis: A cross-sectional study. J Cachexia Sarcopenia Muscle. 10:355–367. 2019.PubMed/NCBI View Article : Google Scholar
5	Alabarse PVG, Lora PS, Silva JMS, Santo RCE, Freitas EC, de Oliveira MS, Almeida AS, Immig M, Teixeira VON, Filippin LI and Xavier RM: Collagen-induced arthritis as an animal model of rheumatoid cachexia. J Cachexia Sarcopenia Muscle. 9:603–612. 2018.PubMed/NCBI View Article : Google Scholar
6	Burmester GR and Pope JE: Novel treatment strategies in rheumatoid arthritis. Lancet. 389:2338–2348. 2017.PubMed/NCBI View Article : Google Scholar
7	Leyendecker A Jr, Pinheiro CCG, Amano MT and Bueno DF: The use of human mesenchymal stem cells as therapeutic agents for the in vivo treatment of immune-related diseases: A systematic review. Front Immunol. 9(2056)2018.PubMed/NCBI View Article : Google Scholar
8	Liu L, Farhoodi HP, Han M, Liu G, Yu J, Nguyen L, Nguyen B, Nguyen A, Liao W and Zhao W: Preclinical evaluation of a single intravenous infusion of hUC-MSC (BX-U001) in rheumatoid arthritis. Cell Transplant. 29(963689720965896)2020.PubMed/NCBI View Article : Google Scholar
9	Shi Y and Wang Y, Li Q, Liu K, Hou J, Shao C and Wang Y: Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 14:493–507. 2018.PubMed/NCBI View Article : Google Scholar
10	Sun Y, Kong W, Huang S, Shi B, Zhang H, Chen W, Zhang H, Zhao C, Tang X, Yao G, et al: Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment. Clin Exp Rheumatol. 35:288–295. 2017.PubMed/NCBI
11	Liu C, Zhang H, Tang X, Feng R, Yao G, Chen W, Li W, Liang J, Feng X and Sun L: Mesenchymal stem cells promote the osteogenesis in collagen-induced arthritic mice through the inhibition of TNF-α. Stem Cells Int. 2018(4069032)2018.PubMed/NCBI View Article : Google Scholar
12	Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, et al: Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 91:1017–1026. 2006.PubMed/NCBI
13	Mushahary D, Spittler A, Kasper C, Weber V and Charwat V: Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A. 93:19–31. 2018.PubMed/NCBI View Article : Google Scholar
14	Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini Fc, Krause Ds, Deans Rj, Keating A, Prockop Dj and Horwitz Em: Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 8:315–317. 2006.PubMed/NCBI View Article : Google Scholar
15	Brand DD, Latham KA and Rosloniec EF: Collagen-induced arthritis. Nat Protoc. 2:1269–1275. 2007.PubMed/NCBI View Article : Google Scholar
16	Miyoshi M and Liu S: Collagen-induced arthritis models. Methods Mol Biol. 1868:3–7. 2018.PubMed/NCBI View Article : Google Scholar
17	Kong X, Zhang Z, Fu T, Ji J, Yang J and Gu Z: TNF-α regulates microglial activation via the NF-κB signaling pathway in systemic lupus erythematosus with depression. Int J Biol Macromol. 125:892–900. 2019.PubMed/NCBI View Article : Google Scholar
18	Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL and Gulko PS: The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum. 52:322–332. 2005.PubMed/NCBI View Article : Google Scholar
19	Oyenihi AB, Ollewagen T, Myburgh KH, Powrie YSL and Smith C: Redox status and muscle pathology in rheumatoid arthritis: Insights from various rat hindlimb muscles. Oxid Med Cell Longev. 2019(2484678)2019.PubMed/NCBI View Article : Google Scholar
20	An L, Li Z, Shi L, Wang L, Wang Y, Jin L, Shuai X and Li J: Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-κB and Notch1 pathways. Nano Lett. 20:7728–7736. 2020.PubMed/NCBI View Article : Google Scholar
21	Park KH, Mun CH, Kang MI, Lee SW, Lee SK and Park YB: Treatment of collagen-induced arthritis using immune modulatory properties of human mesenchymal stem cells. Cell Transplant. 25:1057–1072. 2016.PubMed/NCBI View Article : Google Scholar
22	Park MJ, Lee SH, Moon SJ, Lee JA, Lee EJ, Kim EK, Park JS, Lee J, Min JK, Kim SJ, et al: Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis. Sci Rep. 6(35933)2016.PubMed/NCBI View Article : Google Scholar
23	Wu CC, Liu FL, Sytwu HK, Tsai CY and Chang DM: CD146+ mesenchymal stem cells display greater therapeutic potential than CD146-cells for treating collagen-induced arthritis in mice. Stem Cell Res Ther. 7(23)2016.PubMed/NCBI View Article : Google Scholar
24	Shu J, Pan L, Huang X, Wang P, Li H, He X and Cai Z: Transplantation of human amnion mesenchymal cells attenuates the disease development in rats with collagen-induced arthritis. Clin Exp Rheumatol. 33:484–490. 2015.PubMed/NCBI
25	Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK and Dahlke MH: Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation. 81:1589–1595. 2006.PubMed/NCBI View Article : Google Scholar
26	Santos JM, Bárcia RN, Simões SI, Gaspar MM, Calado S, Agua-Doce A, Almeida SC, Almeida J, Filipe M, Teixeira M, et al: The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis. J Transl Med. 11(18)2013.PubMed/NCBI View Article : Google Scholar
27	Gu J, Gu W, Lin C, Gu H, Wu W, Yin J, Ni J, Pei X, Sun M, Wang F, et al: Human umbilical cord mesenchymal stem cells improve the immune-associated inflammatory and prothrombotic state in collagen type-II-induced arthritic rats. Mol Med Rep. 12:7463–7470. 2015.PubMed/NCBI View Article : Google Scholar
28	Luz-Crawford P, Torres MJ, Noël D, Fernandez A, Toupet K, Alcayaga-Miranda F, Tejedor G, Jorgensen C, Illanes SE, Figueroa FE, et al: The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases. Stem Cells. 34:456–469. 2016.
29	Papadopoulou A, Yiangou M, Athanasiou E, Zogas N, Kaloyannidis P, Batsis I, Fassas A, Anagnostopoulos A and Yannaki E: Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann Rheum Dis. 71:1733–1740. 2012.PubMed/NCBI View Article : Google Scholar
30	Hoogduijn MJ, Roemeling-van Rhijn M, Engela AU, Korevaar SS, Mensah FK, Franquesa M, de Bruin RW, Betjes MG, Weimar W and Baan CC: Mesenchymal stem cells induce an inflammatory response after intravenous infusion. Stem Cells Dev. 22:2825–2835. 2013.PubMed/NCBI View Article : Google Scholar
31	Filippin LI, Teixeira VN, Viacava PR, Lora PS, Xavier LL and Xavier RM: Temporal development of muscle atrophy in murine model of arthritis is related to disease severity. J Cachexia Sarcopenia Muscle. 4:231–238. 2013.PubMed/NCBI View Article : Google Scholar
32	Huffman KM, Jessee R, Andonian B, Davis BN, Narowski R, Huebner JL, Kraus VB, McCracken J, Gilmore BF, Tune KN, et al: Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability. Arthritis Res Ther. 19(12)2017.PubMed/NCBI View Article : Google Scholar
33	Arutyunyan I, Fatkhudinov T, Kananykhina E, Usman N, Elchaninov A, Makarov A, Bolshakova G, Goldshtein D and Sukhikh G: Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: In vitro study. Stem Cell Res Ther. 7(46)2016.PubMed/NCBI View Article : Google Scholar